Quanterix Corp
NASDAQ:QTRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Quanterix Corp
Total Liabilities
Quanterix Corp
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Quanterix Corp
NASDAQ:QTRX
|
Total Liabilities
$123m
|
CAGR 3-Years
18%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Total Liabilities
$56.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Danaher Corp
NYSE:DHR
|
Total Liabilities
$30.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
|
|
Waters Corp
NYSE:WAT
|
Total Liabilities
$2.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Total Liabilities
$5.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Total Liabilities
$23.4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
18%
|
|
Quanterix Corp
Glance View
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 460 full-time employees. The company went IPO on 2017-12-07. The firm is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to reliably detect protein biomarkers at extremely low concentrations in blood, serum and other fluids. Its products include HD-X Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, and 2470 Arrayer. The company also supplies NF-Light antibodies and ELISA kits, which offer solutions for the detection of neurofilament light (Nf-L) for the development of therapeutics and diagnostics for neurodegenerative conditions. Its portfolio of available kits spans multiple therapeutic areas, including cardiology, infectious disease, inflammation, neurology, and oncology. The company provides services through its Simoa Accelerator Laboratory.
See Also
What is Quanterix Corp's Total Liabilities?
Total Liabilities
123m
USD
Based on the financial report for Dec 31, 2025, Quanterix Corp's Total Liabilities amounts to 123m USD.
What is Quanterix Corp's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
14%
Over the last year, the Total Liabilities growth was 61%. The average annual Total Liabilities growth rates for Quanterix Corp have been 18% over the past three years , 14% over the past five years .
